Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of revision of prior period financial statements

	September 30, 2021
	As					As
	Reported		Revisions			Revised
Revised balance sheets
Total current assets	$	180,253,143	$	—		$	180,253,143
Right-of-use assets		45,392,663		11,486,769			56,879,432
Other long-term assets		146,485,099		—			146,485,099
Total assets		372,130,905		11,486,769			383,617,674
Lease liabilities, current portion	$	1,795,528	$	918,254		$	2,713,782
Other current liabilities		38,886,306		—			38,886,306
Total current liabilities		40,681,834		918,254			41,600,088
Long-term debt, net		71,882,615		—			71,882,615
Lease liabilities		46,484,006		10,392,703			56,876,709
Total liabilities		159,048,455		11,310,957			170,359,412
Equity:
Members' equity		121,400,880		8,445,695			129,846,575
Noncontrolling interest		91,681,570		(8,269,883	)		83,411,687
Total equity		213,082,450		175,812			213,258,262
Total liabilities and equity	$	372,130,905	$	11,486,769		$	383,617,674

	Nine Months Ended September 30, 2021
	As						As
	Reported			Revisions			Revised
Revised statements of operations
Net income (loss)	$	154,875,487		$	175,812		$	155,051,299
Less: net income (loss) attributable to noncontrolling interests		37,337,868			(901,383	)		36,436,485
Net income (loss) attributable to Nutex Health Inc.	$	117,537,619		$	1,077,195		$	118,614,814
Revised statements of cash flows
Cash flow from operating activities	$	126,697,442		$	310,896		$	127,008,338
Cash flow from investing activities		(25,088,953	)		(117,164	)		(25,206,117	)
Cash flow from financing activities		(92,884,430	)		(193,732	)		(93,078,162	)
Net change in cash	$	8,724,059		$	—		$	8,724,059

	June 30, 2022
	As						As
	Reported			Revisions			Revised
Revised balance sheets
Equity:
Members' equity	$	525,689,827		$	5,911,300		$	531,601,127
Noncontrolling interest		40,724,416			(5,911,300	)		34,813,116
Total equity	$	566,414,243		$	—		$	566,414,243
		Six Months Ended June 30, 2022
		As						As
		Reported			Revisions			Revised
Revised statements of operations
Net income (loss)	$	1,347,961		$	(519,980	)		827,981
Less: net income (loss) attributable to noncontrolling interests		(786,589	)		(630,886	)		(1,417,475	)
Net income (loss) attributable to Nutex Health Inc.	$	2,134,550		$	110,906			2,245,456

	Three months ended June 30, 2022
	As						As
	Reported			Revisions			Revised
Revised statements of changes in equity
Deconsolidation of Real Estate Entities
Retained earnings	$	(12,267,888	)	$	5,800,942		$	(6,466,946	)
Noncontrolling interest		(27,055,984	)		(5,280,962	)		(32,336,946	)
Total deconsolidation of real estate entities	$	(39,323,872	)	$	519,980		$	(38,803,892	)
Net income (loss)
Retained earnings	$	(19,395,752	)	$	110,906			(19,284,846	)
Noncontrolling interest		(4,082,418	)		(630,886	)		(4,713,304	)
Total net income (loss)	$	(23,478,170	)	$	(519,980	)		(23,998,150	)